A. Kertser

发表

Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner

I. Amit, D. Winter, Eyal David, 2017, Nature Communications.

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

I. Amit, Hadas Keren-Shaul, A. Weiner, 2019, Nature Communications.

IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair.

M. Schwartz, K. Baruch, A. Kertser, 2013, Brain : a journal of neurology.

Aging-induced type I interferon response at the choroid plexus negatively affects brain function

I. Amit, Eyal David, M. Schwartz, 2014, Science.

PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease

I. Amit, Eyal David, M. Schwartz, 2016, Nature Medicine.

Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology

M. Schwartz, A. Spinrad, K. Baruch, 2015, Nature Communications.

Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner

I. Amit, D. Winter, Eyal David, 2017, Nature Communications.

Maternal Type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress

I. Amit, M. Schwartz, A. Spinrad, 2019, Molecular Psychiatry.

Kuti Baruch negatively affects brain function Aging-induced type I interferon response at the choroid plexus

I. Amit, Eyal David, M. Schwartz, 2022 .

Cerebral nitric oxide represses choroid plexus NFκB‐dependent gateway activity for leukocyte trafficking

Ziv Porat, Michal Schwartz, M. Schwartz, 2015, The EMBO journal.

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

I. Amit, Hadas Keren-Shaul, A. Weiner, 2019, Nature Communications.

Corticosteroid signaling at the brain-immune interface impedes coping with severe psychological stress

I. Amit, A. Weiner, M. Schwartz, 2019, Science Advances.

Targeting low levels of MIF expression as a potential therapeutic strategy for ALS

Velina Kozareva, Reto Eggenschwiler, Leenor Alfahel, 2024, Cell reports. Medicine.